Charles River Laboratories
Compensation Insight

How Charles River Laboratories Pays

Charles River's B0 to B12 normalized ladder from Animal Technician I to Corporate Vice President, priced across 23 markets alongside the 2026 Long-Term Incentive Plan's RSUs, PSUs and options, a $15.44M FY2025 CEO package at 251:1, and 151 certified H-1B filings since FY2021.

19,700 employees · NYSE: CRL · Delaware corporation · Wilmington, Massachusetts · FY ends late December
Employees
19,700
Approximate headcount at the 27 December 2025 fiscal year end, down about 2 percent on the year, across more than 120 sites in more than 20 countries.
Voluntary turnover
10.1%
FY2025 voluntary turnover, down from 11.1 percent in FY2024.
FY2025 revenue
$4.02B
Revenue of $4.015 billion for the year ended 27 December 2025; second-quarter FY2026 revenue was $1.004 billion.
Stock-based compensation
$71.1M
FY2025 expense of $71.083 million, against $69.891 million in FY2024 and $72.048 million in FY2023.
CEO total pay
$15.44M
James C. Foster's FY2025 Summary Compensation Table total, of which $11.601 million was stock awards.
CEO pay ratio
251:1
Measured against a $61,430 median employee identified from a population of 19,878 as of 1 November 2025.
EICP payout
139%
The 2025 Executive Incentive Compensation Plan paid 139 percent of target to every named executive, in cash in February 2026.
H-1B median wage
$126,000
Median across 151 certified labour condition applications from FY2021 to FY2026; the FY2025 median runs $110,000 to $133,179 depending on the aggregator.
Locations
United States
Canada
United Kingdom
France
Germany
Netherlands
Ireland
Hungary
India
Australia
Japan
China
South Korea
Singapore
Israel
1.00× base / 1.00× TC vs Wilmington, MA

Band Hierarchy

Charles River publishes job-family ladders, not a grade catalogue. Animal Caretaker I to IV, Animal Technician I to IV, Research Scientist I to VII, Study Director, Associate Scientific Director, Director, Senior Director, General Manager, Executive Director and Corporate Vice President are all visible in careers material; B0 to B10 is a research normalization laid over them so that markets can be compared. Above B10 the ladder becomes an SEC disclosure rather than a career level.

Operations and technician ladder — B0 through B2

B2
Technician II / Analyst IOperations IC · verified
Animal Technician II, Research Analyst I, Technical Trainer I, Archives Associate II, Biomanufacturing Technician II
B1
Assistant / Technician IOperations IC · verified
Animal Caretaker I, Animal Technician I, Sample Coordinator I, Molecular Technologist I, Archives Associate I
B0
Intern / TraineeFoundation · modeled
Intern I and II, student placement, laboratory trainee, biomanufacturing intern

Scientific ladder — B3 through B5

B5
Senior Scientist / Study DirectorSenior scientific IC · verified
Senior Scientist, Study Director, Technical Specialist, Principal Research Analyst, Pharmacokinetics lead
B4
Scientist / Research Scientist IScientific IC · verified
Scientist, Research Scientist I, Senior Associate Scientist, EHS Specialist, Formulations Specialist
B3
Associate Scientist / Research AssociateScientific IC · verified
Associate Scientist I and II, Research Associate, Senior Associate Scientist, Biomanufacturing Technician III

Expert and management fork — B6 through B7

B7
Associate Director / Senior ManagerExpert IC or management · verified
Associate Scientific Director, Associate Director, Senior Manager, Digital Associate Director
B6
Principal Scientist / ManagerExpert IC or management · modeled
Principal Scientist, Laboratory Manager, Team Manager, Operations Manager, Supervisor

Leadership ladder — B8 through B10

B10
Vice President / Corporate Vice PresidentEnterprise leadership · modeled
Vice President, Corporate Vice President, Regional Head, Global Segment Leader
B9
Senior Director / General Manager / Executive DirectorLeadership · verified
Senior Director, General Manager, Executive Director, Global Functional Head
B8
DirectorManagement or expert leadership · verified
Director, Business Development Director, Functional Director, Director of Digital Data Enablement

Disclosed executive layer

Chief Executive Officer
Birgit Girshick from 5 May 2026; James C. Foster through FY2025
Fully disclosed. Foster's FY2025 Summary Compensation Table total was $15,435,220 and Girshick's appointment terms are a $1.2 million base, a 100 percent target bonus and a $9.0 million initial equity target.
Corporate Executive Vice President
Joseph W. LaPlume for Corporate Development and Strategy, Victoria L. Creamer as Chief People Officer, Shannon M. Parisotto for Global Discovery and Safety Assessment
Named executives carry a full compensation table; the rest are visible only through Section 16 filings. The band's incentive target is 70 percent of base and its stock-ownership guideline is 3x base.
Executive Vice President and Chief Financial Officer
Glenn Coleman from February 2026; Flavia H. Pease until 2025
Disclosed through an appointment Form 8-K: an $800,000 base, an 85 percent target bonus, a $3.0 million annual award and a $3,500,000 one-time restricted stock unit grant.
Senior Vice President
Michael G. Knell as Chief Accounting Officer and 2025 interim Chief Financial Officer
Appears in the compensation table only when the officer qualifies as a named executive. Incentive target 50 percent of base; stock-ownership guideline 2x base.
Corporate Vice President
Regional and global function leaders identified in company material but not by name in pay tables
No salary, bonus or grant disclosure exists. The only public marker attaching to the tier is a 1x base stock-ownership guideline once an individual is designated.
Non-employee directors
Martin Mackay, Virginia Wilson, Paul Graves, Nancy Andrews and seven others
Fully disclosed as a governance package. FY2025 totals ran $320,708 to $365,859 and are excluded from the employee ladder.
VerifiedOnly the officer and non-employee-director rows carry a company pay disclosure. Everything in the band table is either a company job posting or a model built around one.

Track divergence

B0 to B2
Operations and animal-care work, much of it hourly and non-exempt in the United States. Progression is inside a numbered job family, from Animal Caretaker I to IV or Animal Technician I to IV, rather than across a grade structure.
B3 to B5
The scientific delivery core, running Associate Scientist to Scientist to Senior Scientist and Study Director. This is where Charles River's public salary evidence is densest, because the company posts explicit United States ranges for these titles.
B6 to B7
The fork. A scientist can carry on as Principal Scientist and then Associate Scientific Director, or move to Laboratory or Team Manager and then Associate Director. Public evidence shows no pay difference between the two paths at the same band.
B8 to B10
Business and function leadership, from Director through Senior Director, General Manager and Executive Director to Corporate Vice President. Salary evidence thins sharply here and no incentive target is published for any of it.
B11 and above
The SEC-disclosed officer population. Pay is set against an international peer market rather than a local salary scale, the incentive target becomes an explicit percentage of base, and equity becomes the majority of the package.

Hierarchy qualifications and legacy structures

  • No official band numbers were found in any reviewed filing, careers page or job posting. B0 to B10 is an analytical catalogue built so that a Tranent scientist and a Reno scientist can be compared, and it should never be quoted back to a recruiter as a Charles River grade.
  • A numeric title suffix is a job-family level, not a company-wide grade. Research Scientist I to VII, Animal Technician I to IV and Biomanufacturing Technician I to III each number independently, so a III in one family is not a III in another.
  • The Roman numeral does not mean entry level. Several Research Scientist I postings asked for around six years of experience, which is why that title is mapped to B4 rather than to the bottom of the ladder.
  • The crosswalk is most reliable in scientific and laboratory-operations families, where Charles River posts explicit United States ranges, and least reliable in sales, business development and digital roles, where variable pay and quota structures are entirely unpublished.
  • Charles River has acquired and divested repeatedly, but no public source documents an enterprise-wide legacy grade conversion or harmonisation matrix, so acquired-site title structures cannot be reconciled here.
  • The officer and director tiers are corporate designations, not the top of an employee ladder, and are carried in the executive section rather than in the band table.

Peer-level mapping

BandArchetypePeer mappingCaveat
B0Intern / TraineeContract-research and life-science tools intern and student placement programmesCharles River publishes no grade code, so every peer row here is a scope comparison rather than a company crosswalk.Midpoint of a $36,000 to $48,000 planning range modelled from entry-level postings; no direct Charles River intern rate was published.
B1Assistant / Technician ILaboratory assistant and technician I roles across the contract-research sectorSeveral of these roles are hourly and non-exempt in the United States, so an annualised figure overstates a part-year or part-time hire.Midpoint of $39,000 to $55,000, anchored on an Animal Research Technician I posting at $22.52 an hour, a Sample Coordinator I at $42,000 and an Archives Associate I at $21 to $23 an hour.
B2Technician II / Analyst IResearch analyst I and technician II roles at diagnostics and CRO peersNumeric suffixes are job-family levels inside a role, not a company-wide grade, so a Technician II in one family need not match a II in another.Midpoint of $45,000 to $68,000, anchored on a Research Analyst I posting at $52,000 plus United States analyst and technical-trainer records.
B3Associate Scientist / Research AssociateResearch associate and associate scientist rungs on a CRO scientific delivery ladderThe Associate Scientist and Research Associate titles overlap in Charles River postings and cannot be ordered reliably from public evidence.Midpoint of $55,000 to $82,000, anchored on an Associate Scientist II posting at $60,000 to $75,000 and a Senior Associate Scientist at $80,000.
B4Scientist / Research Scientist IScientist I and II rungs at contract-research and life-science tools peersThe Roman numeral is misleading here: several Research Scientist I postings asked for six years of experience, so this is not an entry band.Midpoint of $78,000 to $110,000, anchored on Research Scientist I postings at $87,000 to $93,000 in Ashland, from $95,000 in Reno and $100,000 to $110,000 in Shrewsbury.
B5Senior Scientist / Study DirectorSenior scientist and study director rungs across the safety-assessment sectorStudy Director is a regulated GLP accountability, so its market rate is set by study ownership rather than by years of service.Midpoint of $95,000 to $132,000, anchored on a Senior Scientist posting in Wayne, Pennsylvania at $123,000 to $130,000 plus United States salary datasets.
B6Principal Scientist / ManagerPrincipal scientist and laboratory or operations manager rungs at CRO peersThis is where the scientific and people-leadership paths separate, and Charles River publishes no salary difference between the two.Midpoint of $115,000 to $150,000 from cross-source planning evidence; no direct Charles River posting at this band disclosed a range.
B7Associate Director / Senior ManagerAssociate director and senior manager rungs across CRO and diagnostics peersThe Associate Scientific Director title sits on the expert path while Associate Director is usually a people-leadership role at the same band.Midpoint of $140,000 to $180,000, anchored on an Associate Scientific Director posting in Reno at $145,000 to $150,000 plus observed associate-director records.
B8DirectorFunctional and business-unit director rungs at contract-research peersCommercial directors carry sales incentives that are not published, so a business-development director package can sit above this base band.Midpoint of $150,000 to $205,000, anchored on a Director, Equity and Executive Compensation posting at $150,000 to $185,000 plus salary datasets.
B9Senior Director / General Manager / Executive DirectorSenior director, site general manager and executive director rungs at CRO peersA site general manager owns a profit and loss statement while a global functional head does not, and the public evidence cannot separate the two.Midpoint of $190,000 to $260,000, anchored on a Senior Director, Global Quality posting at $200,000 to $240,000; the incentive target for this band is not public.
B10Vice President / Corporate Vice PresidentCorporate vice president and regional leadership tiers at listed CRO peersThis is the last band below the SEC-disclosed population, so it is the widest and least evidenced row in the table.Midpoint of a wide $230,000 to $400,000 planning range. No Charles River vice-president salary or bonus schedule is public; the only disclosure attaching to the band is a 1x base stock-ownership guideline.

Critical evidence warning

Charles River does not publish salary bands, range minimums, midpoints or maximums for any employee population, and it publishes no bonus target and no equity grant schedule below the officer tier. That makes this ladder unusually asymmetric: the United States rungs from Animal Technician I to Senior Director are anchored on real company job postings with disclosed pay ranges, while every non-United States figure is a market-normalised planning estimate derived from the Wilmington anchor and a single city factor. The company's own pay-ratio disclosure shows how thin the international evidence is, with 68 employees in India, 42 in South Korea, 41 in Singapore, 18 in Australia and two in Israel before the de minimis exclusion. Use the United States rows as an orientation and the international rows as a planning envelope, not as a quote of a Charles River scale.


Compensation by Band — Wilmington, MA

Low / median / high annual values at 1.00× base and 1.00× total-compensation factors versus Wilmington, MA. Total equals base plus bonus plus annualized equity.

BandTitleBaseVariableTotal TCEquity
B0
Intern / Trainee
0–1 years · modeled
$36K$48K
$42K
$36K$48K
B1
Assistant / Technician I
0–2 years · verified
$40K$54K
$47K
$40K$54K
B2
Technician II / Analyst I
1–3 years · verified
$48K$65K
$57K
$48K$65K
B3
Associate Scientist / Research Associate
2–5 years · verified
$58K$79K
$69K
$58K$79K
B4
Scientist / Research Scientist I
4–7 years · verified
$80K$108K
$94K
$80K$108K
B5
Senior Scientist / Study Director
6–10 years · verified
$96K$131K
$114K
$96K$131K
B6
Principal Scientist / Manager
8–12 years · modeled
$113K$152K
$133K
$113K$152K
B7
Associate Director / Senior Manager
10–15 years · verified
$136K$184K
$160K
$136K$184K
B8
Director
10–16 years · verified
$151K$204K
$178K
$151K$204K
B9
Senior Director / General Manager / Executive Director
12–18 years · verified
$191K$259K
$225K
$191K$259K
B10
Vice President / Corporate Vice President
15–22 years · modeled
$268K$362K
$315K
$268K$362K
Official location directory · 7 reported band cellsReportedModeledVerifiedEach band's anchor is the midpoint of the bundle's Wilmington base planning range, and base and total use a plus or minus 15 percent envelope around that midpoint. Total equals base for every band because no employee bonus target and no employee grant schedule is publicly evidenced; the bundle's own total column applied a 6 to 80 percent notional employer-cost uplift, which is employer cost rather than pay and has been stripped here.

Total Compensation Range by Band

Total compensation in Wilmington, MA across the employee bands. Ranges are planning envelopes around the median, not offer bands.

B0$36K$48KB1$40K$54KB2$48K$65KB3$58K$79KB4$80K$108KB5$96K$131KB6$113K$152KB7$136K$184KB8$151K$204KB9$191K$259KB10$268K$362K$0$100K$200K$300K$400K

Global Footprint & Pay Arbitrage

Charles River operated more than 120 sites in more than 20 countries at the end of FY2025, with roughly 59 percent of employees in North America, 32 percent in Europe, 7 percent in Asia and 3 percent elsewhere. Wilmington, Massachusetts is the pay anchor and every other market is a single calibration factor against it.

19,700
Employees at 27 December 2025
120+
Sites in more than 20 countries
59 / 32 / 7 / 3
North America, Europe, Asia and other workforce split
10.1%
FY2025 voluntary turnover, down from 11.1%

Office and market catalogue — calibration factors versus Wilmington, MA

LocationLikely office profilePresenceBaseTC
Wilmington, MA
United States · USD
Global headquarters, corporate functions and the executive population disclosed in the proxyOfficial location directory1.00×1.00×
Shrewsbury, MA
United States · USD
Massachusetts laboratory and Discovery and Safety Assessment siteOfficial location directory0.97×0.97×
Reno, NV
United States · USD
Discovery and Safety Assessment site with published scientist and director postingsOfficial location directory0.90×0.90×
Mattawan, MI
United States · USD
Largest single safety-assessment campus in the visa record and the lowest-cost major United States market hereOfficial location directory0.78×0.78×
San Diego, CA
United States · USD
Scientific and commercial presence in a high-cost West Coast biotech clusterOfficial location directory1.08×1.08×
Montréal / Senneville
Canada · CAD
Major Canadian scientific site with direct Study Director and associate-level recordsOfficial location directory0.69×0.69×
Tranent / Edinburgh
United Kingdom · GBP
Largest disclosed United Kingdom scientific site and the European scientist anchorOfficial location directory0.50×0.50×
Cambridge
United Kingdom · GBP
Scientific and commercial presence carrying a Cambridge cluster premium over TranentOfficial location directory0.58×0.58×
Lyon
France · EUR
Scientific and commercial sites in the one European country with a named equity sub-planOfficial location directory0.58×0.58×
Cologne
Germany · EUR
Scientific and commercial presence modelled from European anchorsOfficial location directory0.63×0.63×
Leiden
Netherlands · EUR
Scientific and commercial presence modelled from European anchorsOfficial location directory0.64×0.64×
Dublin / Ballina
Ireland · EUR
Scientific and corporate presence; the highest-factor euro market in this tableOfficial location directory0.65×0.65×
Gödöllő / Budapest
Hungary · HUF
Scientific and support operations; the lowest-cost European market in this tableOfficial location directory0.35×0.35×
Bangalore
India · INR
Small commercial and support footprint; India held 68 employees in the pay-ratio populationOfficial location directory0.16×0.16×
Mumbai
India · INR
Commercial and support presence with a small metropolitan premium over BangaloreOfficial location directory0.17×0.17×
Hyderabad
India · INR
Commercial and support presence; the lowest factor of the three Indian marketsOfficial location directory0.15×0.15×
Melbourne
Australia · AUD
Commercial and laboratory presence; Australia held 18 employees in the pay-ratio populationOfficial location directory0.70×0.70×
Sydney
Australia · AUD
Commercial presence carrying a Sydney uplift over the sparse Melbourne evidenceOfficial location directory0.75×0.75×
Tokyo / Yokohama
Japan · JPY
Commercial and scientific presence with no company-specific salary dataset locatedOfficial location directory0.62×0.62×
Shanghai
China · CNY
Commercial and scientific presence with no company-specific salary dataset locatedOfficial location directory0.40×0.40×
Seoul
South Korea · KRW
Commercial presence; Korea held 42 employees in the pay-ratio populationOfficial location directory0.48×0.48×
Singapore
Singapore · SGD
Regional commercial hub; Singapore held 41 employees in the pay-ratio populationOfficial location directory0.64×0.64×
Jerusalem
Israel · ILS
Smallest disclosed footprint in this table; two employees appeared in the pay-ratio populationOfficial location directory0.70×0.70×

Charles River publishes a location directory but not city-level headcount, so this catalogue cannot rank offices by size. The only geographic population figures in the filings are the regional workforce split and the small per-country counts disclosed in the pay-ratio de minimis analysis.

Wilmington, MA anchor medians — the basis of every modeled cell

BandBaseStockBonusTotal
B1$47K$0$0$47K
B2$57K$0$0$57K
B3$69K$0$0$69K
B4$94K$0$0$94K
B5$114K$0$0$114K
B7$160K$0$0$160K
B8$178K$0$0$178K
B9$225K$0$0$225K
  • Wilmington is the anchor because it is the global headquarters and the only market where company job postings cover the ladder from technician to senior director. Its band medians are the midpoints of those posted ranges.
  • Shrewsbury at 0.97 and Reno at 0.90 are calibrated from direct company postings in those cities, which is why a Research Scientist I is posted at $100,000 to $110,000 in Shrewsbury and from $95,000 in Reno.
  • Mattawan, Michigan at 0.78 is the largest safety-assessment campus in the visa record and the clearest evidence that site choice moves pay more than title does: its captured H-1B median is $76,594 with 87 percent of records below $100,000.
  • Tranent near Edinburgh at 0.50 carries the European scientist anchor, resting on Glassdoor United Kingdom records of £25,000 to £31,000 for a Scientist and £34,000 to £40,000 for a Senior Scientist.
  • Bangalore at 0.16 is the lowest factor in the table and the least evidenced. Charles River disclosed only 68 employees in India in the pay-ratio population, and the sole company-specific Indian salary observation is a two-profile reported average of ₹18.2 lakh.
  • Segment headcount was roughly 11,760 in Discovery and Safety Assessment, 4,140 in Research Models and Services and 2,600 in Manufacturing Solutions, so the scientific bands carry most of the workforce.

Model rules

  • Every non-Wilmington cell is the Wilmington median multiplied by that city's calibration factor and then by the 26 August 2026 foreign-exchange snapshot.
  • Base and total factors are identical for every market and flat across the ladder. Charles River is a site-based laboratory network rather than an offshore delivery model, so the bundle evidences no level-dependent compression to interpolate and no top-of-ladder factor is applied.
  • Total compensation equals base pay in every band. No employee bonus target and no employee grant size is publicly disclosed, so the report shows a real zero rather than a modelled incentive.
  • The bundle's own total column applied a notional employer-cost uplift rising from 1.06x at B0 to 1.8x at B10. That is employer cost, not pay, and it has been removed so base plus bonus plus equity reconciles to total.
  • The officer and chief executive rows are excluded from the band table entirely. Their pay is a global peer-market figure that is identical in every city, and multiplying it by a 0.16 India factor or a 0.50 United Kingdom factor would invent a local executive scale that does not exist.
  • A cell marked modeled is a planning envelope. Only the United States rows anchored on posted company ranges, and the four Glassdoor-anchored international titles, rest on a direct observation.

Variable Pay & Annual Cash Incentive

Charles River discloses its executive cash incentive plan in unusual detail and discloses nothing at all about employee bonus targets. The Executive Incentive Compensation Plan is a single annual cash plan, scored half on global company results and half on business-segment results, and it paid 139 percent of target for 2025.

BandTargetMechanismRecent payout
B0–B10
Every employee band below the officer tier
Not publicly disclosedThe proxy states that employees on short-term incentive plans shared the same 2025 metric architecture as executives, but no target percentage, eligibility threshold or band schedule is published anywhere in the reviewed evidence.Not publicly disclosed
SVP
Senior Vice President
50% of baseAnnual Executive Incentive Compensation Plan on global revenue and operating income plus segment revenue and operating income.139% of target for 2025; Michael Knell's $250,000 target paid $347,500
EVP
Corporate Executive Vice President
70% of baseAnnual Executive Incentive Compensation Plan on the same 50 percent global and 50 percent segment weighting.139% of target for 2025 for both Joseph LaPlume and Victoria Creamer
COO
Chief Operating Officer during 2025
80% of baseAnnual Executive Incentive Compensation Plan.139% of target for 2025; Birgit Girshick's $620,000 target paid $861,800
CFO
Executive Vice President and Chief Financial Officer
85% of baseAnnual Executive Incentive Compensation Plan, prorated for 2026 under the February 2026 offer terms.Not publicly disclosed
CEO
Chief Executive Officer
100% of baseAnnual Executive Incentive Compensation Plan with a 200 percent maximum payout; the same target applies to Birgit Girshick from May 2026.139% of target for 2025; James Foster's $1,570,263 target paid $2,182,666
ModeledVerifiedFor 2025 the plan weighted 50 percent on global company revenue and operating income and 50 percent on the relevant business segment's revenue and operating income. Nothing funded below 85 percent of target performance, maximum performance was set at 109 percent and the payout was capped at 200 percent of target. The result was a uniform 139 percent payout across the named executives, settled in cash in February 2026, and the committee explicitly made no discretionary adjustment. Joseph LaPlume was paid $563,612 and Victoria Creamer $547,386 at that same 139 percent factor, but their individual dollar targets are not separately stated in the reviewed evidence, so only the three disclosed targets appear in the outcome table. Flavia Pease, the former Chief Financial Officer, received no incentive payment for 2025.

Executive incentive targets — percent of salary

Chief Executive Officer
100% of base
James Foster's 2025 target was $1,570,263; Birgit Girshick carries the same 100 percent rate from May 2026 on a $1.2 million base.
Chief Operating Officer
80% of base
Birgit Girshick's 2025 target as Chief Operating Officer was $620,000, the step between the executive vice president tier and the chief executive.
Chief Financial Officer
85% of base
Glenn Coleman's 2026 target under his appointment terms, above the standard corporate executive vice president rate.
Corporate Executive Vice President
70% of base
The standard rate for the corporate executive vice president tier, covering Corporate Development and Strategy, the Chief People Officer and Global Discovery and Safety Assessment.
Senior Vice President
50% of base
The lowest disclosed target in the plan; Michael Knell's 2025 target was $250,000 while serving as Chief Accounting Officer and interim Chief Financial Officer.

Named-executive outcomes

ExecutiveTargetPaidAttainment
James C. Foster$1,570,263$2,182,666139% of target
Birgit Girshick$620,000$861,800139% of target
Michael G. Knell$250,000$347,500139% of target

Employee payout timing and history

There is no published employee payout percentage for any year. The proxy describes employees on short-term incentive plans sharing the same global and segment metric architecture, which confirms that non-executive incentive plans exist, but it does not publish a target by band, an eligibility rule, a payout history or a cadence. Monthly, quarterly and semiannual arrangements are not disclosed either; the Executive Incentive Compensation Plan itself is strictly annual.

Sales and special incentives

Charles River runs a commercial ladder from Client Manager through Business Development Director and Senior Business Development Director to Regional Sales Director, and those roles almost certainly carry quota-based variable pay. No quota, commission rate, accelerator, draw or split structure is published in any reviewed source, so no sales incentive is modelled anywhere in this report. Spot bonuses, project incentives and deal bonuses are in the same position: plausible, role-specific and entirely unevidenced.


Equity — RSUs, PSUs, Options & ESPP

Charles River is a New York Stock Exchange issuer, so employee equity means restricted stock units, performance share units, options and an employee stock purchase plan rather than an Indian-style employee stock ownership plan. The active platform changed on 5 May 2026, when shareholders approved the 2026 Long-Term Incentive Plan and new grants under the 2018 plan stopped.

2026 Long-Term Incentive Plan
Active; board-adopted 11 March 2026 and shareholder-approved 5 May 2026
Verified
Permits options, stock appreciation rights, restricted stock, restricted stock units, performance share units and other share-based awards. Full-value awards consume two units of the fungible pool while options and stock appreciation rights consume one. At least 95 percent of awards are subject to minimum vesting provisions. The plan prohibits evergreen replenishment, discounted options, repricing and liberal share recycling, and a French sub-plan applies local qualified-award rules.
Reserve: 4,825,000 shares registered on Form S-8 in May 2026
2026 Long-Term Incentive Plan exhibit, accession 0000950103-26-007060, and Form S-8 accession 0000950103-26-006962
Amended and Restated 2018 Incentive Plan
Closed to new grants after 5 May 2026; outstanding awards continue on their original terms
Verified
Options, restricted stock units, performance share units and other awards. Existing grants keep their original vesting and performance terms, so a 2024 or 2025 award is unaffected by the change of plan.
Reserve: 2,274,083 shares remained available at 16 March 2026 and did not roll into the new plan
2026 proxy statement, accession 0001104659-26-037367
Employee Stock Purchase Plan
Existence confirmed for United States employees; current terms not verified
Verified
Employees may purchase company shares through payroll deduction. The company's benefits pages list stock purchase and the insider-trading policy regulates purchase elections while an employee holds material non-public information. The discount, any lookback, the offering period length and the current share capacity were not located in any reviewed public document.
Reserve: Not publicly disclosed
Charles River careers and benefits pages and the company insider-trading policy
Deferred Compensation Plan
Active for a select group of eligible employees
Verified
Permits deferral of compensation with an investment-crediting framework. It is not a share pool and creates no dilution. Eligibility criteria and individual balances are not broadly disclosed.
Reserve: Not a share pool
FY2025 Form 10-K, accession 0001100682-26-000022
  • Share usage, the company's own burn-rate measure, was 1.05 percent in 2023, 0.95 percent in 2024 and 1.34 percent in 2025, for a three-year average of 1.11 percent. The 2025 rise came alongside the restructuring rather than alongside headcount growth.
  • Stock-based compensation expense has been remarkably flat: $72.048 million in 2023, $69.891 million in 2024 and $71.083 million in 2025, against a workforce that fell from roughly 21,800 to 19,700 over the same period.
  • The 2018 plan's 2,274,083 unused shares were deliberately not carried into the 2026 plan, so the 4,825,000 newly registered shares are the whole current authority rather than an addition to an existing balance.
  • At the $297.64 report-date reference share price a $1 million target grant is roughly 3,360 shares before valuation discounts, performance leverage and grant-date price differences. Grant-date fair value in the filings governs, not this illustration.

Equity plan capacity and grant activity

423,164
Restricted stock units granted in 2025
709,061 units were outstanding at the proxy measurement date; the split by band or country is not disclosed.
222,930
Performance share units granted in 2025
336,640 target units were outstanding, roughly half the restricted unit population, consistent with a senior-only programme.
~21,000
Options granted in 2025
Weighted-average exercise price about $135 and a $61.63 weighted-average grant-date fair value. 670,509 options remained outstanding at $228.55 with 6.12 years of term left.
1.34%
2025 share usage rate
Against 0.95 percent in 2024 and 1.05 percent in 2023, for a 1.11 percent three-year average.

Vesting — common reported employee schedule

Year 1
25%
+25% · annual tranche
Year 2
50%
+25% · annual tranche
Year 3
75%
+25% · annual tranche
Year 4
100%
+25% · annual tranche

Restricted stock units principally vest over four years and executive annual awards commonly vest ratably across that period; options also vest over four years with a ten-year term. Performance share units do not follow this schedule at all. They run a single three-year performance period and settle once, so the four-year table applies to the restricted and option components only. Under the French sub-plan no award may vest before the first anniversary, and if vesting occurs before two years a holding period runs until the second anniversary.

Eligibility by hierarchy level

  • The plan permits awards to eligible employees, officers, directors and other service providers, but Charles River publishes no minimum eligible band, no routine grant size below senior leadership and no pool utilisation by grade. Plan eligibility is not evidence that every employee receives stock.
  • The public evidence supports exact executive grants, general award mechanics and the existence of a United States employee stock purchase plan. It does not support a conclusion either way about routine grants at B0 to B8, which is why this report shows a real zero in the band table rather than a guess.
  • The first band with any public equity marker at all is B10, where a designated Corporate Vice President becomes subject to a 1x base stock-ownership guideline. That is evidence of senior equity participation, not evidence of a minimum grant size.
  • Stock-ownership guidelines rise steeply through the officer tier: 1x base at Corporate Vice President, 2x at Senior Vice President, 3x at Corporate Executive Vice President and 6x at Chief Executive Officer.
  • Non-employee directors receive equity under the separate director compensation programme, with FY2025 totals generally between $320,708 and $365,859 including cash retainers, subject to a plan cap and holding requirements.
  • 2025 performance share units were scored on first-year non-GAAP earnings per share plus three-year relative total shareholder return, paying 0 to 200 percent. The relative return component adjusts the base result by plus or minus 35 percentage points, and a result below 90 percent of the earnings target pays nothing for the whole grant.

Named executive target equity

ExecutiveTargetUnits / structure
Birgit Girshick
Chief Executive Officer from 5 May 2026
$9.0M initial target fair value80 percent performance share units and 20 percent restricted stock units, the most performance-weighted mix disclosed by the company, with eligible retirement treatment and an expected change-in-control agreement providing 3x salary plus target bonus on a qualifying double-trigger termination.
James C. Foster
Chair, President and Chief Executive Officer during FY2025
$11.601M FY2025 stock awardsGrant-date value reported in the Summary Compensation Table, about 75 percent of his $15,435,220 total. A separate transition grant accompanied the January 2026 chief executive succession announcement.
Glenn Coleman
Executive Vice President and Chief Financial Officer
$3.0M annual award plus $3.5M one-timeThe annual award is 60 percent performance share units and 40 percent restricted stock units. The one-time $3,500,000 restricted unit award vests 25 percent a year over four years and sits alongside $1,875,000 of staged new-hire cash.
Joseph W. LaPlume
Corporate Executive Vice President, Corporate Development and Strategy
$2.261M FY2025 stock awardsAnnual grant made in the second quarter after the annual meeting; a 5,257-unit restricted award followed on 29 May 2026 at $180.71 a share.
Victoria L. Creamer
Corporate Executive Vice President and Chief People Officer
$2.106M FY2025 stock awardsThe lowest corporate executive vice president grant in the FY2025 table. Her August 2026 option exercise at a $179.66 strike shows that legacy option grants from earlier plans are still live in this population.
VerifiedThe employee stock purchase plan is the one equity component an ordinary Charles River employee can size for themselves, and it is also the least documented. Its existence is confirmed by the company's United States benefits pages and by the insider-trading policy, which regulates purchase elections made while an employee holds material non-public information. The discount percentage, whether there is a lookback, the offering period length and the remaining share capacity were not found in any reviewed public filing or plan document, so no purchase value is modelled anywhere in this report. Anyone weighing an offer should ask for the plan prospectus directly rather than assuming a standard 15 percent discount.

Executive Compensation

FY2025 Summary Compensation Table values from the 2026 proxy statement filed 31 March 2026. Equity is a grant-date accounting value rather than cash received, and the table belongs to James Foster's final year as chief executive rather than to the current leadership.

CEO total — James C. Foster
$15.44M
Stock awards are 75.2% of the reported total; salary 10% and non-equity incentive 14%
10%
14%
75%
Salary $1.55M
Incentive $2.18M
Equity $11.60M
Base salary$1,545,636
Executive Incentive Compensation Plan payout at 139% of target$2,182,666
Stock awards at grant-date value$11,601,089
All other compensation$105,829
Reported total$15,435,220

Reading the package

Stock awards were about 75 percent of James Foster's FY2025 reported total and salary about 10 percent, with the cash incentive contributing 14 percent at a 139 percent payout. That is an equity-weighted package by any standard but noticeably less extreme than large-cap technology, where salary can fall below 3 percent of the total. The successor package pushes further in the same direction: Birgit Girshick's $9.0 million initial equity target against a $1.2 million base is 80 percent performance share units, so four fifths of her grant value can settle anywhere between zero and twice target.

CEO-to-median-employee ratio
251:1
Median employee $61,430 · The median employee was identified from a population of 19,878 employees as of 1 November 2025, using the de minimis country exclusions the rules permit. Because the population is global and Charles River is a laboratory and manufacturing operator rather than a professional-services firm, the $61,430 median sits far below a United States-only median would..
Peer CEO comparison
IQVIA · Ari Bousbib · FY2025$28.13M
IQVIA 2026 proxy statement filed 27 February 2026
Charles River Laboratories · James C. Foster · FY2025$15.44M
Charles River 2026 proxy statement filed 31 March 2026
Medpace · August J. Troendle · FY2025$11.44M
Medpace 2026 proxy statement filed 16 March 2026
Illumina · Jacob Thaysen · FY2025$11.02M
Illumina 2026 proxy statement

This comparison is deliberately narrow, limited to current 2026 proxy disclosures for directly comparable contract-research and life-science issuers. Charles River's own 2025 compensation peer group is far broader at 37 companies spanning contract-research organisations, life-science tools, diagnostics, pharmaceuticals and medical devices, and its consultant regressed the peer data to Charles River's revenue while weighting proxy data 75 percent against survey data 25 percent. Foster's total sits at 1.82 times below IQVIA and about 1.35 times above Medpace and Illumina.


Named Executive Officers & Board

Charles River changed both of its most senior officers inside four months of 2026. Birgit Girshick, previously Chief Operating Officer, became Chief Executive Officer on 5 May 2026 and James Foster moved to a non-executive director seat after decades leading the company. Glenn Coleman became Chief Financial Officer in February 2026, following Michael Knell's interim period and Flavia Pease's departure.

James C. Foster · Chair, President and Chief Executive Officer during FY2025$15.44M
Salary $1.55M · Cash incentive $2.18M · Stock $11.60M · Other $106K · Equity 75.2%
Birgit Girshick · Chief Operating Officer during FY2025; Chief Executive Officer from 5 May 2026$5.90M
Salary $761K · Cash incentive $862K · Stock $4.12M · Other $152K · Equity 69.9%
Joseph W. LaPlume · Corporate Executive Vice President, Corporate Development and Strategy$3.51M
Salary $570K · Cash incentive $564K · Stock $2.26M · Other $119K · Equity 64.3%
Victoria L. Creamer · Corporate Executive Vice President and Chief People Officer$3.33M
Salary $554K · Cash incentive $547K · Stock $2.11M · Other $125K · Equity 63.2%
Flavia H. Pease · Former Executive Vice President and Chief Financial Officer$2.95M
Salary $508K · Cash incentive $0 · Stock $2.41M · Other $35K · Equity 81.6%
Michael G. Knell · Senior Vice President and Chief Accounting Officer; interim Chief Financial Officer in 2025$2.11M
Salary $448K · Cash incentive $348K · Stock $1.20M · Other $117K · Equity 56.7%

The FY2025 table is a transition-year artefact and should be read as such. Foster's numbers are a full year as chief executive; Girshick's are a full year as chief operating officer, not as chief executive, so her $5,898,392 total understates the role she now holds. Pease appears with $2,409,546 of stock awards but a zero cash incentive, the signature of a departure before the payout date. Knell's row mixes a Senior Vice President base with the workload of an interim Chief Financial Officer. The forward-looking numbers that actually describe the current leadership are in the appointment filings rather than in this table: a $1.2 million chief executive base with a 100 percent target and $9.0 million of initial equity, and an $800,000 chief financial officer base with an 85 percent target, a $3.0 million annual award and $3.5 million of one-time restricted units.

Board compensation framework

ElementAmountNotes
Highest FY2025 director total$365,859Martin Mackay, reflecting additional chair or lead-director responsibilities.
Typical full-year director total$320,708 to $345,859Virginia Wilson at $345,859, Paul Graves at $345,708, Nancy Andrews, Reshema Kemps-Polanco and Craig Thompson at $340,859 and George Llado at $325,859.
Lowest FY2025 director total$320,708Steven Barg, Abraham Ceesay and Mark Enyedy, the floor of the disclosed range.
StructureCash retainer plus annual equityThe programme combines cash retainers with an annual equity award; the individual retainer and committee fee schedule was not captured in the reviewed evidence.
Ownership and holding rulesApplicableDirectors are subject to the company's stock-ownership and holding requirements and to a cap on total annual director compensation under the plan.

Ten non-employee directors were disclosed for FY2025 in a tight $320,708 to $365,859 band, a spread of only 14 percent between the highest and lowest paid. Nancy Andrews sold 573 shares on 18 August 2026 at $285.24, the only director open-market transaction in the captured Form 4 window.

Regional heads and other officers

Shannon M. Parisotto, Corporate Executive Vice President for Global Discovery and Safety Assessment, is an active Section 16 filer with two open-market sales in August 2026 but did not qualify as a named executive for FY2025, so no compensation table exists for her. The same is true of every Corporate Vice President and every regional or segment leader: Charles River identifies these leaders in company material but discloses their pay only if an SEC rule forces it. Individual regional-head compensation is therefore not publicly disclosed.


Insider Trades — SEC Forms 3/4/5

Charles River is a New York Stock Exchange-listed Delaware corporation, so the governing record is SEC Section 16 Forms 3, 4 and 5 rather than any Indian exchange filing. Indian SEBI takeover and promoter-group concepts do not apply, and no separate employee stock ownership trust or promoter allotment exists. A Form 4 disposal is not automatically a bearish discretionary sale: an award code marks a grant or a vesting, a withholding code marks shares surrendered to cover tax, and a gift code often marks an estate-planning transfer with no change in beneficial ownership.

DatePersonTransactionSharesPriceValue
2026-08-19
Shannon M. Parisotto
Corporate Executive Vice President, Global Discovery and Safety Assessment
Sale
Open-market sale under a Rule 10b5-1 plan; accession 0001100682-26-000136.
2,039$294.12$600K
2026-08-18
Nancy C. Andrews
Non-employee director
Sale
Open-market sale; the only director transaction in the captured window. Accession 0001100682-26-000134.
573$285.24$163K
2026-08-10
Joseph W. LaPlume
Corporate Executive Vice President, Corporate Development and Strategy
Gift
Gift or transfer at no stated price; accession 0001100682-26-000128.
257$0
2026-08-06
Victoria L. Creamer
Corporate Executive Vice President and Chief People Officer
Exercise
Option exercise at a $179.66 strike with a same-day sale; accession 0001100682-26-000122.
4,179$259.16$1.08M
2026-08-05
Shannon M. Parisotto
Corporate Executive Vice President, Global Discovery and Safety Assessment
Sale
Open-market sale under a Rule 10b5-1 plan; accession 0001100682-26-000120.
5,046$263.00$1.33M
2026-06-29
James C. Foster
Non-executive director; former Chair, President and Chief Executive Officer
Sale
The largest transaction in the window, made under a Rule 10b5-1 plan seven weeks after handing over the chief executive role. Accession 0001100682-26-000111.
75,000$225.00$16.88M
2026-06-05
Birgit Girshick
Chief Executive Officer
Gift
Transfer to a revocable trust with no change in beneficial ownership; accession 0001100682-26-000107.
3,386$0
2026-05-29
Glenn Coleman
Executive Vice President and Chief Financial Officer
Award
Restricted stock unit grant, part of the annual second-quarter grant cycle. Accession 0001100682-26-000101.
6,640$180.71$1.20M
2026-05-29
Joseph W. LaPlume
Corporate Executive Vice President, Corporate Development and Strategy
Award
Restricted stock unit grant on the same annual grant date, with tax withholding reported on later dates. Accession 0001100682-26-000097.
5,257$180.71$950K
2026-05-26
Victoria L. Creamer
Corporate Executive Vice President and Chief People Officer
Withholding
Shares withheld to cover tax on a vesting; accession 0001100682-26-000085.
346$158.52$55K
2026-01-30
James C. Foster
Chair, President and Chief Executive Officer at the transaction date
Settlement
Performance share unit vesting with shares withheld for taxes, the largest settlement in the window. Accession 0001100682-26-000012.
39,031$211.68$8.26M

Reading guide

Grant cadenceAnnual executive equity grants cluster in the second quarter shortly after the annual meeting. The 29 May 2026 awards to Glenn Coleman and Joseph LaPlume at $180.71 a share are that cycle.
Vesting cadenceThe 30 January 2026 Foster settlement of 39,031 shares is a performance share unit vesting for a completed three-year cycle, not a discretionary purchase.
Share price contextTransactions in the window ran from $158.52 in May to $294.12 in August 2026 against a $297.64 report-date reference price, so the same number of units was worth roughly 85 percent more at the end of the window than at the start.
Succession signalThe two gift-coded transfers, LaPlume's 257 shares and Girshick's 3,386 shares into a revocable trust, are estate-planning moves with no change in beneficial ownership rather than sales.

Benefits & Perks

Charles River publishes benefits at category level rather than as a quantified package, and it does so almost exclusively for the United States. Outside North America the company-specific evidence effectively runs out, so the rows below separate what Charles River actually says from the statutory baseline an employee would fall back on.

United States

  • Retirement401(k) with a company match. Substantially all United States employees are eligible on employment and the 2025 company plan cost was $26.9 million. The match formula is not published: an executive offer referenced 3 percent while employee reports commonly cite 4 percent, so no universal percentage is asserted here. [official]
  • MedicalMedical, dental and vision cover with flexible spending accounts. Confirmed by the company benefits pages at category level. Carriers, deductibles, coverage tiers and the employer share of premium are not publicly disclosed. [official]
  • ProtectionLife and accidental death cover, short- and long-term disability, critical illness options. Listed on the benefits pages. Multiples of salary, benefit caps and elimination periods are not published. [official]
  • LeavePaid time off, holidays and volunteer time. A current job posting confirms all three categories. Entitlement by tenure and site is not published; employee reports citing 15 paid days plus separate sick or flexible days are anecdotal. [official]
  • GrowthTuition reimbursement and career development. Public benefits pages confirm reimbursement and structured development. Annual caps, approval rules and any repayment clawback on early departure vary and are not published. [official]
  • EquityEmployee stock purchase plan. Confirmed to exist for United States employees by the benefits pages and the insider-trading policy. The discount, lookback, offering period and remaining capacity were not verified in any reviewed document. [official]
  • SupportEmployee assistance programme, employee assistance fund, legal services and discounts. Described publicly at category level alongside recognition and referral programmes. No provider, benefit limit or eligibility rule is published. [official]

Global programs

  • GrowthProfessional development and career development programmes. Described in global careers material at category level. Specific vendors such as LinkedIn Learning, Udemy or Coursera were not verified in any reviewed source. [official]
  • WellbeingEmployee assistance and wellbeing programmes. Referenced globally in careers material. Session limits, providers and dependant eligibility are not published. [official]
  • Community11 employee resource groups with roughly 3,000 members. The single hardest global engagement figure the company publishes, equivalent to about 15 percent of the workforce participating in at least one group. [official]
  • RecognitionRecognition and referral programmes. Confirmed at category level for the United States. Award values, referral bonus amounts and eligibility rules are not published. [official]
  • MobilitySabbatical policy and global remote-work entitlement. No formal sabbatical policy and no global remote or hybrid working entitlement was verified in any reviewed source. [npd]

Benefit fields not publicly quantified

Charles River's benefit disclosure is asymmetric in the same way its pay disclosure is. The United States rows come from company benefits pages and job postings; almost everything else in this table is a government rule that sets the floor, not a description of what Charles River actually provides. The company's own defined-contribution plan cost of $26.9 million for 2025 is the only quantified benefit figure in the filings. Treat any international row marked as a statutory baseline as the minimum an employer must do, and confirm the actual package in the offer documents.


Performance Review & Pay Progression

Charles River publishes no performance framework. There is no public rating scale, no calibration or distribution policy, no global review calendar for employees and no merit matrix. What is disclosed is the executive calendar, because SEC rules force it: 2025 base salaries were approved on 20 May 2025 and took effect on 29 June 2025, and annual equity awards are generally granted in the second quarter shortly after the annual meeting.

Not publicly disclosed

No authoritative global rating scale was located, whether numeric, lettered or labelled. Employee discussion cannot establish a policy.
No calibration or forced-distribution policy was located, so no bell curve should be assumed either way.
The employee review timeline is not published. An annual cadence is plausible from public employee comments but no globally uniform effective date exists in any reviewed source.
No company-wide merit matrix and no 2026 merit budget was disclosed. Employee comments citing 2 to 3 percent recent increases are anecdotal.
No official minimum tenure in band and no promotion increase percentage was located for any level.
No global probation or confirmation policy exists publicly; these are country and contract specific.
No separate rating scale for individual contributors against people managers was evidenced, although the job families themselves clearly differ.
No global adjusted gender or race pay-gap statistic was located. The proxy cites internal equity and performance ratings among the factors used to set pay, and the human-capital material describes inclusion programmes, but no controlled equal-pay regression is published.

Modeled promotion planning timeline

BandYears to next scopePromotion hikeStatus
B00.5–1.5 years to B1Not disclosedModeled planning interval
B11–2 years to B2Not disclosedModeled planning interval
B21–3 years to B3Not disclosedModeled planning interval
B32–4 years to B4Not disclosedModeled planning interval
B42–4 years to B5Not disclosedModeled planning interval
B52–5 years to B6 or B7Not disclosedModeled planning interval
B62–4 years to B7Not disclosedModeled planning interval
B72–4 years to B8Not disclosedModeled planning interval
B82–5 years to B9Not disclosedModeled planning interval
B93–6 years to B10Not disclosedModeled planning interval
B10Selection-based; the move to the officer tier resets the packageNot disclosedModeled planning interval

The one part of the calendar with real visibility is the executive cycle: salary actions approved in May and effective at the end of June, with annual equity granted in the second quarter after the annual meeting. The 29 May 2026 restricted stock unit grants to Glenn Coleman and Joseph LaPlume at $180.71 a share are that cycle in the Form 4 record. Nothing equivalent is published for the employee population, and no market-correction or off-cycle adjustment schedule was found, so any local adjustment should be confirmed with the hiring manager or in the offer letter.

Pay progression evidence

Modelled progression, not Charles River policy: B0 to B1 typically takes 0.5 to 1.5 years for a 5 to 12 percent increase; B1 to B2 takes 1 to 2 years for 6 to 12 percent; B2 to B3 takes 1 to 3 years for 8 to 15 percent; B3 to B4 takes 2 to 4 years for 8 to 18 percent; B4 to B5 takes 2 to 4 years for 8 to 18 percent; B5 to B6 or B7 takes 2 to 5 years for 10 to 20 percent depending on whether the path is expert or management; B7 to B8 takes 2 to 4 years for 10 to 20 percent; B8 to B9 takes 2 to 5 years for 12 to 25 percent; and B9 to B10 takes 3 to 6 years for 15 to 30 percent. The move from B10 into the officer tier is selection-based and resets the package entirely rather than applying a percentage. Within a job family the numbered rungs move faster than these band transitions, because Animal Technician I to II or Research Scientist I to II is a step inside a band rather than a step across one.


H-1B / LCA Visa Footprint — United States

Charles River is a light and inconsistent H-1B sponsor by technology-company standards, and the public aggregators disagree with each other about even the basic FY2025 count. Labour condition application wages are a role and location wage commitment in base salary terms, not total compensation, and they are not a payroll census or an approval record.

Certified filings FY2021–FY2026
151
The best captured cross-year series, at a $91,000 twenty-fifth percentile, a $126,000 median and a $159,000 seventy-fifth percentile.
FY2025 applications
37 to 39
h1bdata.info extracted 37 records and Ellis 39 for the same year, a difference driven by extraction scope rather than by any company action.
FY2025 median wage
$110,000 to $133,179
Ellis reports $110,000, h1bdata.info $113,740 and H1BGrader $133,179. MyVisaJobs reports a $131,471 average against a $124,916 average prevailing wage.
Petition approval rate
Not publicly disclosed
No captured source reconciles I-129 petitions, initial approvals, extensions and denials into a company-level rate, so none is asserted here.

Dataset summary

DatasetResultInterpretation
h1bdata.info FY202537 records at a $113,740 median5 percent of records above $200,000 and 16 percent between $150,000 and $200,000. A snapshot by that aggregator's extraction.
Ellis FY202539 labour condition applications at a $110,000 medianA different extraction of the same underlying Department of Labor disclosure data, two records higher and $3,740 lower on the median.
H1BGrader FY2025$133,179 median with a $275,525 maximumThe highest median of the four, with no record count shown in the captured result, so the denominator cannot be checked.
MyVisaJobs FY2025$131,471 average proffered wageAn average rather than a median, against a $124,916 average prevailing wage, so the premium over prevailing wage is about 5 percent.
Ellis FY2021–FY2026 history151 certified filings at $91,000 / $126,000 / $159,000The only captured source with a full quartile distribution, and the basis for the single city row below.

City-level H-1B wage history

CityP25MedianP75Records
United States, all worksites
Certified filings FY2021 to FY2026, the only captured distribution with quartiles
$91K$126,000$159K151

All-years aggregates. P25/P75 are rounded reconstruction values marked modeled; medians and record counts are the stronger fields.

Selected title / worksite records

TitleWorksiteProffered wageNotes
Site concentrationMattawan, Michigan$76,594 median across 30 recordsThe largest single worksite in the captured location data. 87 percent of its records sit below $100,000, consistent with scientific and support titles at a lower-cost site rather than with a senior technical mix.
Senior Data EngineerNolensville, Tennessee$160,000 median across 2 recordsThe highest captured worksite median and a two-record sample, so it describes a specific hire rather than a site pay level.
Scientist 2United States, captured dataset$108,150 median across 2 recordsA title-specific sample too small to compare against the B4 or B5 band medians with any confidence.
Formulations SpecialistHorsham, Pennsylvania$76,003A single certified filing, included because it is the only Pennsylvania anchor in the visa record.
Prevailing wage level mixUnited States, FY2021 to FY2026$84,000 / $105,000 / $120,000 / $153,000Department of Labor wage levels I to IV with 29, 55, 7 and 60 filings respectively. The distribution is barbelled: level II and level IV together carry 76 percent of filings while level III carries only 5 percent.

Reading the data correctly

  • A labour condition application is a wage commitment for a role at a worksite, not a payroll record, a total compensation figure or an approved petition. It excludes any bonus and any equity.
  • Only one row in the city table carries quartiles, because the captured aggregators publish a median without a distribution for every individual worksite. Mattawan, Nolensville and the title-level anchors are therefore shown as examples rather than as distributions.
  • The four FY2025 aggregators disagree on both count and median by wide margins. Any single figure quoted from one of them without naming the source is unreliable.
  • No reconciled company-level USCIS approval rate exists in any reviewed source, and the underlying research file deliberately stores that field as null rather than inserting an unsupported percentage.
  • The visa population is a small and skewed slice of a 19,700-person workforce concentrated in laboratory operations, so it should not be read as representative of Charles River pay generally.

Key Nuances & Insights

01This is a job-family company, not a band-code company

Research Scientist I to VII, Animal Technician I to IV and Biomanufacturing Technician I to III give real progression clues inside a function, but they number independently and none of them is a company-wide grade. Anyone converting a title into a corporate grade without internal human-resources data is inventing structure that Charles River has never published.

02The total column equals base, and that is a finding rather than a gap

No employee bonus target and no employee grant size is disclosed at any band below the officer tier. The honest total for B0 to B10 is therefore base pay. The underlying research file computed a total by applying a notional employer-cost uplift rising from 1.06 times at B0 to 1.8 times at B10; that is what an employee costs, not what an employee is paid, and it has been stripped here.

03A Research Scientist I is not an entry-level job

Several United States Research Scientist I postings asked for around six years of experience, which is why the title maps to B4 rather than to the bottom of the ladder. The Roman numeral marks a rung inside a scientific family that starts above the technician ladder, not the first job in the company.

04Site choice moves pay more than title does

The same Research Scientist I title was posted at $87,000 to $93,000 in Ashland, Ohio, from $95,000 in Reno and $100,000 to $110,000 in Shrewsbury, Massachusetts. That is a 15 percent spread on an identical title inside one country, and Mattawan's captured visa median of $76,594 sits lower again. Negotiating the site is a real lever.

05The 139 percent payout was uniform, which tells you how the plan works

Every named executive was paid at exactly 139 percent of target for 2025 and the committee applied no discretionary adjustment. The Executive Incentive Compensation Plan is a formula on global and segment revenue and operating income, not a judgement call, so an individual performance rating does not move the executive cash number.

06The plan has a hard cliff most people miss

Nothing funds below 85 percent of target performance, and for 2025 performance share units a result below 90 percent of the earnings-per-share target pays zero for the entire grant rather than a reduced amount. The relative total shareholder return modifier then moves the base result by plus or minus 35 percentage points on top of that.

07Equity switched platforms in the middle of 2026

New grants under the 2018 plan stopped on 5 May 2026 and its 2,274,083 unused shares were deliberately not carried forward. Anyone holding a 2024 or 2025 award keeps their original terms; anyone joining after May 2026 is on the new 4,825,000-share plan, where a restricted or performance unit consumes two pool units against one for an option.

08India is not an offshore delivery centre

Charles River disclosed 68 employees in India in the FY2025 pay-ratio population, alongside 42 in South Korea, 41 in Singapore, 18 in Australia and two in Israel. Applying information-technology-services concepts such as offshore band structures or onsite allowances to this footprint would misstate the operating model entirely.

09Geographic compression is flat here, unlike in technology

Because equity is not evidenced below the officer tier, there is no senior stock component to narrow the international gap at the top of the ladder. A Tranent scientist sits at roughly half the Wilmington median at both junior and senior bands, where a comparable technology company would show the offshore ratio climbing sharply with seniority.

10Restructuring makes year-over-year pay comparisons unsafe

Headcount fell about 8 percent in 2024 and about 2 percent more in 2025, 15 smaller sites were closed, the Hanover cell-therapy site shut in February 2026 and European discovery assets and the cell-solutions business were divested. Every one of those changes moves the employee mix, the median pay figure and the local sample sizes behind these bands.

11The current chief executive has no completed pay year

The $15,435,220 headline belongs to James Foster's final full year. Birgit Girshick's own terms are forward-looking appointment figures, a $1.2 million base, a 100 percent target and a $9.0 million initial equity target, and no FY2026 Summary Compensation Table exists for her yet. The next proxy will change the headline number materially.

12H-1B data is a wage anchor, not a payroll census

Four aggregators report FY2025 medians between $110,000 and $133,179 on counts between 37 and 39 records. A labour condition application is a base-salary commitment for a role at a worksite, excludes bonus and equity, and says nothing about whether the petition was approved.

13The lateral-versus-internal question cannot be answered here

No Charles River dataset publicly separates lateral hires from internal promotees at the same level. Glenn Coleman's $1,875,000 of staged new-hire cash and $3,500,000 one-time restricted units show what an external senior hire can command, but that is an officer appointment and generalising it downward would be speculation.

Research control

Against directly comparable 2026 proxy disclosures James Foster's $15,435,220 sat 1.82 times below IQVIA's Ari Bousbib and about 1.35 times above Medpace and Illumina, placing Charles River second of four. The 251:1 pay ratio is high for the sector, but the driver is the denominator rather than the numerator: a $61,430 global median employee reflects a laboratory, animal-care and manufacturing workforce spread across more than 120 sites, not a professional-services population. On the employee side the United States scientific ladder from Associate Scientist to Senior Director tracks the contract-research market closely, while the absence of any disclosed employee bonus or equity means a Charles River package is more cash-dominated than a comparable role at a life-science tools company.

Evidence classification

LabelMeaningExamples and permitted use
VerifiedA Charles River SEC filing, an official company benefits or careers page, a company job posting with a disclosed pay range, or a government rule.Executive and director compensation, the pay ratio, equity plan terms and share counts, incentive plan mechanics, headcount, turnover, revenue and the United States band anchors.
ReportedA named third-party dataset with observable records, chiefly Glassdoor, Levels.fyi, Indeed, PayScale, Comparably and the visa aggregators.The United Kingdom, Australian, Canadian, French and Indian title observations and the whole H-1B wage distribution.
ModeledThe Wilmington anchor median multiplied by a single city calibration factor and the 26 August 2026 foreign-exchange snapshot, inside a plus or minus 15 percent planning envelope.Every non-United States cell, plus the B0, B6 and B10 anchors where no company posting disclosed a range.
Not publicly disclosedNo source in the research bundle supports a figure.Recorded as such rather than estimated, most visibly for employee bonus targets, employee equity grants and the employee stock purchase plan terms.

Explicit “Not publicly disclosed” index

Any official enterprise-wide band or grade identifier, and any title-to-grade mapping
Salary range minimum, midpoint and maximum by band for every population
Target bonus percentage, eligibility threshold and payout history below the officer tier
Employee equity grant size, minimum eligible band and grant frequency below senior leadership
Employee stock purchase plan discount, lookback, offering period and share capacity
The 401(k) match formula as a company-wide percentage
City-level headcount anywhere in the world, and country headcount outside the pay-ratio de minimis disclosure
Merit increase percentage, merit budget and the global salary review effective date
Performance rating scale, calibration policy and promotion increase matrix
Compensation for Corporate Vice Presidents, regional heads and any officer who is not a named executive
Sales quota, commission rate, accelerator and draw structures for the commercial ladder
Any lateral-hire premium against internal promotees at the same level
A controlled adjusted gender or race pay-gap statistic
Benefit provider, coverage level and employer premium share in every market outside the United States

Known gaps and diligence before relying on a cell

  1. 1Only one research bundle exists for Charles River, so no cross-bundle disagreement had to be resolved. The trade-off is that every figure rests on a single research pass and no second extraction was available to check it against.
  2. 2The officer and chief executive rows are deliberately excluded from the band table. Their pay is a global peer-market figure that appears identically in every city table in the source material, and applying a 0.16 India factor or a 0.50 United Kingdom factor to a $1.2 million chief executive base would manufacture a local executive scale that does not exist. Those figures are carried in the executive section instead, and the employee ladder runs B0 to B10 at seniority 1 to 11.
  3. 3The source model computed total compensation as base multiplied by a notional employer-cost uplift running from 1.06 times at B0 to 1.8 times at B10. That is employer cost rather than pay, so it has been removed and total has been rebuilt from components, which makes total equal base for every band.
  4. 4City calibration factors are the bundle's own planning multipliers rather than observed ratios in most markets. Only Shrewsbury, Reno, Mattawan, Tranent, Montréal, Lyon, Melbourne and Bangalore have any direct local observation behind them, and Bangalore's rests on a two-profile reported average.
  5. 5Base and total factors are identical and flat across the ladder, and no top-of-ladder factor is applied, because the source model evidences no level-dependent geographic compression for this operating model. If Charles River does grant equity below the officer tier, the real international ratios would widen at senior bands and these factors would understate them.
  6. 6The four H-1B aggregators cannot be merged. FY2025 counts run 37 against 39 and medians run $110,000 against $113,740 against $133,179, and no captured source publishes a reconciled USCIS approval rate, so none is stated.
  7. 7The 2023 headcount of roughly 21,800 is inferred from the disclosed 2024 percentage decline rather than separately disclosed, and is labelled as such in the workforce table.
  8. 8The employee stock purchase plan is confirmed to exist but none of its economics were verified, so no purchase discount value appears anywhere in this report.
  9. 9No company-wide 2026 salary increase percentage, pay freeze, salary cut, campus offer revision or off-cycle correction was located in any reviewed source.

FX rates used — 1 USD equals, snapshot 2026-08-26

95.2135
INR
0.733
GBP
1.392
AUD
0.8569
EUR
1.3852
CAD
159
JPY
6.7829
CNY
1384.48
KRW
1.2699
SGD
309.1
HUF
2.9744
ILS

Single-date conversion layer for comparability; it ignores payroll-date FX, tax, purchasing power, benefits valuation and hedging. Compensation intelligence, not legal, tax, investment, immigration or employment advice.

Source register — 19 sources

DEF 14A 2026Charles River Laboratories 2026 Proxy Statement, accession 0001104659-26-037367 · United States Securities and Exchange Commission · 2026-03-31. Executive and director compensation, the Executive Incentive Compensation Plan, the equity plan proposal, the pay ratio, stock-ownership guidelines, share usage rates and the compensation peer group.
10-K FY2025Form 10-K for the year ended 27 December 2025, accession 0001100682-26-000022 · United States Securities and Exchange Commission · 2026-02-18. Headcount, voluntary turnover, revenue, the geographic and segment workforce split, benefit plan cost, stock-based compensation expense and restructuring.
10-Q Q2 2026Form 10-Q for the quarter ended 27 June 2026, accession 0001100682-26-000118 · United States Securities and Exchange Commission · 2026-08-06. Second-quarter revenue, backlog, restructuring progress, repurchases and portfolio changes.
8-K CEOChief executive transition Form 8-K, accession 0001628280-26-001603 · United States Securities and Exchange Commission · 2026-01-08. Birgit Girshick's appointment terms and James Foster's transition grant.
8-K CFOChief financial officer appointment Form 8-K, accession 0000950103-26-002326 · United States Securities and Exchange Commission · 2026-02-18. Glenn Coleman's base, target bonus, annual equity, staged new-hire cash and one-time restricted stock unit award.
2026 LTIPCharles River 2026 Long-Term Incentive Plan, accession 0000950103-26-007060 · United States Securities and Exchange Commission · 2026-05-05. Plan authority, eligible award types, fungible-share ratio, minimum vesting, prohibited practices and the French sub-plan.
S-8 2026Form S-8 registration for the 2026 Long-Term Incentive Plan, accession 0000950103-26-006962 · United States Securities and Exchange Commission · 2026-05-31. Registration of 4,825,000 shares under the new plan.
Forms 4Charles River Section 16 Forms 4 filed January to August 2026 · United States Securities and Exchange Commission · 2026-08-19. Grants, performance unit vesting, tax withholding, estate-planning transfers, option exercises and open-market sales.
CareersCharles River careers role-family pages and job postings with disclosed United States ranges · Charles River Laboratories · 2026-08-26. Job-family ladders, titles, benefit categories and every United States band anchor from Animal Research Technician I to Senior Director.
LocationsCharles River global locations directory · Charles River Laboratories · 2026-08-26. Confirmation that every city in this report is an official Charles River location.
GlassdoorGlassdoor Charles River salary records for the United States, United Kingdom and Australia · Glassdoor · 2026-08-26. United Kingdom Scientist, Senior Scientist and Study Director ranges and a four-salary Australian sample used only as low-confidence anchors.
Levels.fyiLevels.fyi Charles River compensation records · Levels.fyi · 2026-08-26. Cross-functional United States total compensation medians and ranges.
IndeedIndeed salary pages and company job mirrors · Indeed · 2026-08-26. United States, United Kingdom, Canadian and French salary observations including the Lyon Study Director average.
PayScalePayScale Research Scientist at Charles River Laboratories · PayScale · 2026-08-26. Research Scientist range and average used to check the B4 anchor.
ComparablyComparably Charles River Laboratories compensation · Comparably · 2026-08-26. Modelled company-wide salary and bonus estimates, used only as a cross-check and never as a payroll record.
H-1B extractsh1bdata.info, H1BGrader, MyVisaJobs and Ellis Charles River extracts · Third-party Department of Labor aggregators · 2026-08-26. FY2025 and cross-year wage distributions, worksite medians, title anchors and prevailing wage level mix.
Statutory baselinesEPFO, India Ministry of Labour, Australian Taxation Office, Fair Work Ombudsman, UK Government pensions and leave guidance, Government of Canada labour standards · National governments and statutory agencies · 2026-08-26. The Provident Fund, gratuity, maternity, superannuation, leave, auto-enrolment pension and vacation floors quoted in the benefits table.
Peer proxiesIQVIA, Medpace and Illumina 2026 proxy statements · United States Securities and Exchange Commission · 2026-03-16. Peer chief executive compensation comparison.
FX snapshotPublic mid-market foreign-exchange references · Public mid-market rate sources · 2026-08-26. Every local currency conversion in this report; informational rates rather than transaction rates.

Recent News & Workforce Trend

Charles River's 2026 has been a governance and restructuring year rather than a pay year. Both top officers changed, the equity platform was replaced, two businesses were divested and no company-wide salary action was announced in any reviewed source.

~21,800
FY2023 employees
Inferred from the disclosed 2024 percentage decline rather than separately disclosed; voluntary turnover for the year was not captured.
~20,100
FY2024 employees
Down about 8 percent on the year with voluntary turnover of 11.1 percent.
~19,700
FY2025 employees
Down about 2 percent with voluntary turnover easing to 10.1 percent.

The workforce shrank about 10 percent across two years while stock-based compensation expense stayed flat between $69.9 million and $72.0 million, so equity spend per remaining employee rose even though no new employee grant programme was announced. Voluntary turnover falling from 11.1 to 10.1 percent alongside site closures is a mixed signal: fewer people are leaving by choice, but the population they are leaving is smaller and has already absorbed involuntary reductions. Median employee compensation for FY2025 was $61,430, and comparable prior-year medians should be read from each proxy's own methodology rather than treated as a series, because the population and the selection change year to year.

6 Aug 2026
Second-quarter results and updated guidance

Second-quarter revenue was $1.004 billion. Management maintained a 2026 focus on operating execution while the divestitures reduced the reported growth base.

Company Q2 2026 release and Form 10-Q
5 May 2026
Shareholders approve the 2026 Long-Term Incentive Plan

The new plan registered 4,825,000 shares and ended new grants under the 2018 plan, whose 2,274,083 remaining shares did not roll over.

SEC Form 8-K and Form S-8
5 May 2026
Birgit Girshick becomes Chief Executive Officer

Her terms are a $1.2 million base, a 100 percent target annual cash incentive and a $9.0 million initial equity target split 80 percent performance share units and 20 percent restricted stock units. James Foster moved to a non-executive director seat.

SEC Form 8-K dated 8 January 2026
31 Mar 2026
2026 proxy statement discloses a 251:1 pay ratio and a 139 percent incentive payout

James Foster's FY2025 total was $15,435,220 against a $61,430 median employee identified from 19,878 employees as of 1 November 2025. Every named executive was paid at 139 percent of target with no discretionary adjustment.

SEC Form DEF 14A, accession 0001104659-26-037367
25 Feb 2026
Portfolio divestitures announced

Certain European discovery assets were sold to IQVIA and the contract development and manufacturing cell-solutions business to GI Partners, reshaping the revenue and margin profile and moving affected employees out of the Charles River population.

Reuters and company disclosures
18 Feb 2026
Glenn Coleman appointed Chief Financial Officer

Offer terms are an $800,000 base, an 85 percent target bonus, a $3.0 million annual equity award split 60 percent performance and 40 percent restricted units, $1,875,000 of staged new-hire cash and a $3,500,000 one-time restricted unit award vesting over four years.

SEC Form 8-K, accession 0000950103-26-002326
18 Feb 2026
FY2025 Form 10-K reports headcount, turnover and benefit cost

Approximately 19,700 employees at 27 December 2025, voluntary turnover of 10.1 percent, revenue of $4.015 billion, stock-based compensation of $71.083 million and a United States defined-contribution plan cost of $26.9 million.

SEC Form 10-K, accession 0001100682-26-000022
3 Feb 2026
Hanover, Maryland cell-therapy site closure reported

The closure followed earlier Wilmington reductions and continued the contraction of the manufacturing footprint that began in 2024.

Fierce Pharma
30 Jan 2026
Chief executive performance share units vest at 39,031 shares

James Foster's completed three-year performance cycle settled at a $211.68 reference price for $8.26 million gross, with shares withheld for taxes. It is the largest settlement in the captured Form 4 window.

SEC Form 4, accession 0001100682-26-000012
8 Jan 2026
Chief executive succession announced

The Form 8-K set out Birgit Girshick's appointment and compensation terms and James Foster's transition grant, four months before the change took effect at the annual meeting.

SEC Form 8-K, accession 0001628280-26-001603
27 Dec 2025
Year-end workforce lower by about 2 percent

Charles River closed FY2025 with approximately 19,700 employees and 10.1 percent voluntary turnover, against roughly 20,100 and 11.1 percent a year earlier.

FY2025 Form 10-K
8 Nov 2024
Site consolidation and workforce reduction

Reporting described the closure of 15 smaller sites and a planned workforce reduction of roughly 3 percent, part of a programme management expected to reach about $300 million of cumulative annualised cost savings by the end of 2026.

Endpoints News and company restructuring disclosures
Last updated 2026-08-27